Retatrutide is being discussed in relation to muscle preservation because of its next-generation metabolic mechanism and strong weight-loss results
- eGFR (CKD-EPI 2009 formula)
Review the result itself, the direction of change, the size of the change, associated symptoms, and the timing relative to medication initiation or dose escalation
Chronic Weight Management: Wegovy and Zepbound are specifically FDA-approved for adults with obesity or overweight with at least one weight-related comorbidity
Early studies show promising weight loss results, but common side effects include nausea, vomiting, diarrhea and increased heart rate
Some of the GLP-1s approved to treat T2D, such as Ozempic, are also widely known to be used for weight loss